Mohammad Sameer Khan

644 total citations
17 papers, 442 citations indexed

About

Mohammad Sameer Khan is a scholar working on Biomaterials, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Mohammad Sameer Khan has authored 17 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Biomaterials, 7 papers in Biomedical Engineering and 6 papers in Molecular Biology. Recurrent topics in Mohammad Sameer Khan's work include Nanoparticle-Based Drug Delivery (7 papers), Nanoplatforms for cancer theranostics (4 papers) and Advancements in Transdermal Drug Delivery (2 papers). Mohammad Sameer Khan is often cited by papers focused on Nanoparticle-Based Drug Delivery (7 papers), Nanoplatforms for cancer theranostics (4 papers) and Advancements in Transdermal Drug Delivery (2 papers). Mohammad Sameer Khan collaborates with scholars based in India, Saudi Arabia and Malaysia. Mohammad Sameer Khan's co-authors include Prashant Kesharwani, Shadma Wahab, B.H. Jaswanth Gowda, Amirhossein Sahebkar, Tanuja Singh, Nazim Nasir, Mallikarjuna Rao Pichika, Waleed Hassan Almalki, Mahak Fatima and Garima Gupta and has published in prestigious journals such as International Journal of Pharmaceutics, International Journal of Biological Macromolecules and Drug Discovery Today.

In The Last Decade

Mohammad Sameer Khan

16 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohammad Sameer Khan India 11 185 121 121 67 45 17 442
Lingran Du China 11 188 1.0× 109 0.9× 141 1.2× 63 0.9× 59 1.3× 22 457
Mahdie Hemati Iran 11 167 0.9× 118 1.0× 90 0.7× 56 0.8× 45 1.0× 25 414
Zhipeng Li China 14 190 1.0× 145 1.2× 144 1.2× 47 0.7× 35 0.8× 38 534
Junjian Li China 15 274 1.5× 143 1.2× 104 0.9× 100 1.5× 40 0.9× 27 699
Jianxin Wang China 12 239 1.3× 144 1.2× 140 1.2× 31 0.5× 52 1.2× 27 539
Changzheng Sun China 9 117 0.6× 107 0.9× 97 0.8× 40 0.6× 42 0.9× 15 341
Madhu Sharma India 12 173 0.9× 112 0.9× 93 0.8× 39 0.6× 45 1.0× 36 395
Kaipei Luo China 11 147 0.8× 119 1.0× 103 0.9× 39 0.6× 25 0.6× 15 354
Alin Moldovan Romania 13 205 1.1× 164 1.4× 173 1.4× 110 1.6× 95 2.1× 22 551

Countries citing papers authored by Mohammad Sameer Khan

Since Specialization
Citations

This map shows the geographic impact of Mohammad Sameer Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Sameer Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Sameer Khan more than expected).

Fields of papers citing papers by Mohammad Sameer Khan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammad Sameer Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Sameer Khan. The network helps show where Mohammad Sameer Khan may publish in the future.

Co-authorship network of co-authors of Mohammad Sameer Khan

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammad Sameer Khan. A scholar is included among the top collaborators of Mohammad Sameer Khan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammad Sameer Khan. Mohammad Sameer Khan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Khan, Mohammad Sameer, Garima Gupta, Mohammed Ghazwani, et al.. (2025). Translational Insights into Stimuli-Responsive Magnetic Nanoparticles for Breast Cancer Treatment. Molecular Pharmaceutics. 22(8). 4494–4511. 9 indexed citations
2.
Khan, Mohammad Sameer, et al.. (2025). Enhanced permeability and retention (EPR) effect: Advances in nanomedicine for improved tumor targeting. Biomaterials Advances. 181. 214636–214636.
3.
Khan, Mohammad Sameer, Garima Gupta, Abdulrhman Alsayari, Shadma Wahab, & Prashant Kesharwani. (2025). Harnessing MUC1 aptamer-targeted nanoparticles for precision medicine in breast cancer. International Journal of Pharmaceutics. 678. 125721–125721. 6 indexed citations
4.
Khan, Mohammad Sameer, et al.. (2025). Exosome-mediated communication in pancreatic cancer: From molecular crosstalk to clinical translation. International Journal of Biological Macromolecules. 320(Pt 1). 145766–145766. 8 indexed citations
5.
Almalki, Waleed Hassan & Mohammad Sameer Khan. (2025). Burden of diabetes mellitus on health and economy of the Arab world: current situation and perspectives. Journal of Public Health. 8 indexed citations
6.
Khan, Mohammad Sameer, et al.. (2024). Nanotools as potential approach in effective management of acne. Journal of Drug Delivery Science and Technology. 102. 106380–106380. 12 indexed citations
7.
Khan, Mohammad Sameer, Garima Gupta, Abdulrhman Alsayari, et al.. (2024). Advancements in liposomal formulations: A comprehensive exploration of industrial production techniques. International Journal of Pharmaceutics. 658. 124212–124212. 15 indexed citations
8.
Khan, Mohammad Sameer, B.H. Jaswanth Gowda, Nazeer Hasan, et al.. (2024). Carbon nanotube-mediated platinum-based drug delivery for the treatment of cancer: Advancements and future perspectives. European Polymer Journal. 206. 112800–112800. 44 indexed citations
9.
Khan, Mohammad Sameer, Mahak Fatima, Shadma Wahab, Mohammad Khalid, & Prashant Kesharwani. (2024). Gallic acid loaded self-nano emulsifying hydrogel-based drug delivery system against onychomycosis. Nanomedicine. 19(25). 2065–2083. 36 indexed citations
10.
Khan, Mohammad Sameer, Mohammad Y. Alshahrani, Shadma Wahab, Garima Gupta, & Prashant Kesharwani. (2024). Evolution of artificial intelligence as a modern technology in advanced cancer therapy. Journal of Drug Delivery Science and Technology. 98. 105892–105892. 22 indexed citations
11.
Khan, Mohammad Sameer, Mahak Fatima, Garima Gupta, Shadab Md, & Prashant Kesharwani. (2024). Recent progress in zein nanoparticles: A promising approach for advancing cancer therapy. Journal of Drug Delivery Science and Technology. 97. 105770–105770. 24 indexed citations
12.
Khan, Mohammad Sameer, B.H. Jaswanth Gowda, Nazim Nasir, et al.. (2023). Advancements in dextran-based nanocarriers for treatment and imaging of breast cancer. International Journal of Pharmaceutics. 643. 123276–123276. 104 indexed citations
13.
Khan, Mohammad Sameer, Sradhanjali Mohapatra, Punnoth Poonkuzhi Naseef, et al.. (2023). Potential of Lipid-Based Nanocarriers against Two Major Barriers to Drug Delivery—Skin and Blood–Brain Barrier. Membranes. 13(3). 343–343. 33 indexed citations
14.
Khan, Mohammad Sameer, B.H. Jaswanth Gowda, Waleed Hassan Almalki, et al.. (2023). Unravelling the potential of mitochondria-targeted liposomes for enhanced cancer treatment. Drug Discovery Today. 29(1). 103819–103819. 61 indexed citations
15.
Khan, Mohammad Sameer, Afsana Sheikh, Mohammed A. S. Abourehab, Neelima Gupta, & Prashant Kesharwani. (2023). Understanding the theranostic potential of quantum dots in cancer management. Materials Today Communications. 36. 106424–106424. 37 indexed citations
16.
Khan, Mohammad Sameer, Sradhanjali Mohapatra, Tahir Khuroo, et al.. (2022). Raw Materials, Technology, Healthcare Applications, Patent Repository and Clinical Trials on 4D Printing Technology: An Updated Review. Pharmaceutics. 15(1). 116–116. 22 indexed citations
17.
Khan, Mohammad Sameer, et al.. (2017). Social Support of Male and Female Care Givers of Individuals Suffering From Schizophrenia. International Journal of Indian Psychology. 4(2). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026